Catalyst Wire Dossier Catalyst Wire Dossier

Trivalent Influenza Virus Vaccine

influenza vaccine, trivalent · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trivalent Influenza Virus Vaccine, covering 2015-10-16 to 2015-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years [Phase 4]

See pricing